Cellectar Biosciences (CLRB) Other Operating Expenses (2010 - 2018)

Cellectar Biosciences (CLRB) posted Other Operating Expenses of $1.7 million for Q4 2018, up 7096.07% sequentially from $23283.0 in Q4 2015.

Cellectar Biosciences (CLRB) Other Operating Expenses (2010 - 2018) Analysis & Trends

Cellectar Biosciences has reported Other Operating Expenses for 6 years, with the latest figure at $1.7 million in Q4 2018.

Quarterly Other Operating Expenses changed N/A year-over-year to $1.7 million in Q4 2018, while the trailing twelve-month figure through Sep 2019 was $1.7 million (changed N/A YoY) and the FY2018 annual result came in at $1.7 million, changed N/A from the prior year.
Other Operating Expenses rose to $1.7 million in Q4 2018 per CLRB's latest filing, from $23283.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $1.7 million in Q4 2018 and troughed at $1.0 in Q4 2014.
A 3-year average of $300130.0 and a median of $89848.0 in 2015 frame the typical range for Other Operating Expenses.
The sharpest annual moves came in 2014 and 2015: Other Operating Expenses plunged 100.0% in 2014, then surged 2328200.0% in 2015.
Over 3 years, Other Operating Expenses stood at $1.0 in 2014, then soared by 2328200.0% to $23283.0 in 2015, then surged by 7096.07% to $1.7 million in 2018.
According to Business Quant data, Other Operating Expenses over the past three periods registered $1.7 million, $23283.0, and $89848.0 for Q4 2018, Q4 2015, and Q3 2015 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Cellectar Biosciences	6.73 Mn	6.73 Mn	-

Download Data